Headquarters
632 RUSSELL ST, COVINGTON, KY 41011-2312, US
COVINGTON, KY, US
BEXION PHARMACEUTICALS INC
From the company
Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing a first-in-class biologic therapy targeting fundamental drivers of solid tumor progression. Its lead program, BXQ-350, is a novel modulator of sphingolipid metabolism designed to selectively target dysregulated sphingolipids common in tumor cells, with encouraging Phase 1b/2a data in metastatic colorectal cancer.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.